Evaluation of The Efficacy and Safety of Tixel Treatment for the Treatment of Facial and/or Scalp Actinic Keratoses
NACompletedINTERVENTIONAL
Enrollment
20
Participants
Timeline
Start Date
May 14, 2020
Primary Completion Date
April 19, 2021
Study Completion Date
April 19, 2021
Conditions
Actinic Keratoses
Interventions
DEVICE
Tixel
Non-invasive thermo-mechanical treatment
Trial Locations (1)
49100
Rabin Medical Center, Ha'Sharon Campus, Petah Tikva
All Listed Sponsors
lead
Novoxel Ltd.
INDUSTRY
NCT04527653 - Evaluation of The Efficacy and Safety of Tixel Treatment for the Treatment of Facial and/or Scalp Actinic Keratoses | Biotech Hunter | Biotech Hunter